Document Preview Unavailable
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: post hoc analysis of phase III trials using patient-reported outcomes
Astermark Jan; Hermans Cédric; Ezzalfani Monia; Sidhom Alaeddine; Barbier Sylvaine; et al. Therapeutic Advances in Hematology Vol. 14, (Jan 2023).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library